4Vajzovic LM, Murray TG, Aziz - Sultan MA, et al. Supraselective in- tra- arterial chemotherapy:evaluation of treatment- related compli- cations in advanced retinoblastoma [ J ]. Clin Ophthalmol, 2011,5 : 171 - 176.
5Linn Murphree A. Intraocular retinoblastoma the case for a new group classificationE J：. Ophthalmol Clin North Am,2(X： ,18( 1 ) :41 -53.
6Shields CL, Shields JA. Diagnosis and management of retinoblasto- ma[ J]. Cancer Control. 2004,11 (5) :317 -327.
7Kim J-W, Abranlson DI4, Dunkel U. Current management strategies for intraocular retinoblastoma[ J ]. Drugs ,2007,67 (15) :2173 - 2185.
8Shields CL, Shelil A, Cater J, et al. Development of new retinoblas- tomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients[ J]. Arch Ophthalmol,2003,121 (11) :1571 - 1576.
9Rodriguez - Galindo C, Chantada GL, Haik BG, et al. Treatment ofretinob|astoma: current status and future perspectives [ J ]. Curt Treat Options Neuro1,2007,9 (4) :294 - 307.
